Stage III Non-Small Cell Lung Cancer AJCC v7 Terminated Phase 2 Trials for Crizotinib (DB08865)

Also known as: Stage III Lung Non-Small Cell Cancer AJCC v7

IndicationStatusPhase
DBCOND0090379 (Stage III Non-Small Cell Lung Cancer AJCC v7)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01822496Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung CancerTreatment